Why the study?
Right ventricular failure is a leading cause of death in pulmonary arterial hypertension with no promising leads in treatment, while metabolic abnormalities may contribute pathologically.
Does diet and exercise improve right ventricular failure in patients with pulmonary arterial hypertension?
Does diet and exercise improve right ventricular failure in patients with pulmonary arterial hypertension?
Diet and exercise interventions may offer a novel therapeutic approach to target metabolic abnormalities and improve right ventricular failure in patients with pulmonary arterial hypertension.
Answers are grounded in this paper and cite their sources.
No effective RV failure therapies in PAH yet; leaves open targeted metabolic research for future trials.
Current pharmacologic treatments for pulmonary arterial hypertension lead to vasodilation of the pulmonary arteries, increasing cardiac output and reducing pulmonary vascular resistance in patients with pulmonary arterial hypertension. Right ventricular failure is a leading cause of death in patients with pulmonary arterial hypertension, but there remain no promising leads in the treatment of right ventricular failure. Current research demonstrates that metabolic abnormalities, particularly regarding insulin resistance and glucose intolerance, may be pathologic in the development of right ventricular failure in patients with pulmonary arterial hypertension. In this review, we will address the potential role diet and exercise may play in improving right ventricular failure in patients with pulmonary arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: